
Commerce Department nixes ‘safety' in NIST AI institute rebrand
President Trump's cabinet continues to overhaul federal programs and initiatives, with some recent AI-related moves hitting the Department of Commerce.
Secretary Howard Lutnick announced that the AI Safety Institute will now be called the Center for AI Standards and Innovation (CAISI). In addition to removing 'safety' from the title of the agency, which was created under the Biden administration in 2023 to set AI standards and guidance, CAISI will pivot to focus more on national security risks and global competitiveness.
'For far too long, censorship and regulations have been used under the guise of national security. Innovators will no longer be limited by these standards,' Lutnick said in a press release. 'CAISI will evaluate and enhance U.S. innovation of these rapidly developing commercial AI systems while ensuring they remain secure to our national security standards.'
The Commerce Department did not respond to Technical.ly's request for comment, including to provide examples of 'censorship.'
CAISI also houses a consortium, established in 2024, of more than 200 companies and organizations that was originally created to develop science-based safety standards for AI operation and design. The group, known as the US AI Safety Institute Consortium, includes several universities and startups from throughout the Mid-Atlantic.
That group remains in operation following this announcement, but there are suspicions that it will shut down, according to a person with knowledge about the consortium.
CAISI and the consortium's formation under the previous administration was spurred by an executive order by former President Joe Biden, which the Trump administration revoked during his early days in office.
Priorities for this newly-renamed government body include plans to ink voluntary agreements with AI developers and companies that can pinpoint risks to national security. That strategy isn't entirely new.
Under the Biden administration, the National Institute of Standards and Technology — the regulatory agency, housed under the Commerce Department, that hosts CAISI — signed memoranda of understanding to undergo AI safety research with US-based AI companies like OpenAI and Anthropic.
In these new evaluations, CAISI will prioritize looking at use cases in cybersecurity and chemical weapons, per the release.
CAISI leadership will also collaborate with the Department of Defense, Department of Homeland Security and intelligence agencies to 'conduct evaluations and assessments.'
This move comes as states are grappling with how to regulate AI. Nearby Virginia did not follow through with passing blanket legislation regulating the technology, and House Republicans are torn over a federal budget provision that would ban states from regulating AI for a decade.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Technical.ly
a day ago
- Technical.ly
Vesteck aims to turn aortic aneurysm surgery into a one-and-done procedure
When it comes to treating potentially deadly aortic aneurysms, medicine has come a long way. One Philly biotech startup aims to make those outcomes even better. Minimally invasive surgery on an aortic aneurysm — an enlargement of the heart's main artery that can cause a fatal rupture if left untreated — requires intensive follow-up care, with additional surgeries often required after two to five years. The likelihood of having to repeat the surgery is a reality that patients have to live with, but it doesn't have to be that way, said Joseph Rafferty, CEO and cofounder of Vesteck, a company that has developed a procedure that can reinforce aortic aneurysm surgery with high-tech stitches called endosutures. 'Physicians tell us, if it was their mom and dad having a procedure like this, they would want a device like this to make sure that they're not going to have to come back for a second procedure,' Rafferty told Using a simple catheter-based approach, Vesteck addresses this critical challenge in treating aortic aneurysms with a developing technology that has the potential to help patients with other medical conditions. Proud Philly roots West Chester-based Vesteck is a global startup with three founders from different parts of the world. But at its core, it's a Philly company. 'I'm a Philly guy, Delaware County, Temple [University] grad,' Rafferty said. 'We have very strong and very, very proud roots in Philadelphia.' Those Philly roots, he said, included a strong work ethic. 'I'm second-oldest of nine, and my wife is seven of 11, so we all understand the concept of 'pumping the pump,'' Rafferty said. 'If you don't pump the pump, money doesn't come out. So we all learned at a very young age that you need to go work and make your money.' When he attended Temple in the 1970s, Rafferty majored in communications and journalism. 'I was a writer with the concept that in whatever business you go into, if you can articulate your thoughts appropriately, it's amazing how many different businesses that skill set can translate to,' he said. After graduating in 1979, Rafferty soon found himself in the booming medical device industry, where he was surrounded by 'the best and the brightest' physicians and surgeons making an impact on patients' lives. 'You can make a very nice living at it if you're willing to make the sacrifices,' Rafferty said. '[It involved] lots of late nights delivering devices.' By the late 2010s, Rafferty knew the medical device industry well and was looking for the next big thing. Through a friend, he met John Edoga, a general surgeon from Columbia University. 'Dr. Edoga shared with me the concept that is Vesteck,' Rafferty said. 'But more importantly, he shared with me the challenges in the aortic repair space.' Along with a third cofounder, French cardiothoracic surgeon Thierry Richard, Vesteck was founded in 2019. Securing the post-surgical health of aortic aneurysm patients At the center of Vesteck's biotechnology is its proprietary endosuture called Suture-Tight. Endosutures allow surgeons to stitch a patient internally using an endoscope, a less invasive surgical tool that enters the patient's body through the groin rather than cutting the patient open. After the initial grafting surgery on the aortic aneurysm, a surgeon using Vesteck's technology re-enters and 'stitches' the grafts in place by attaching the Suture-Tight endosutures. These endosutures, which resemble tiny hoop earrings, are made of nitinol, a nickel-titanium alloy known for its shape memory. Since modern coronary stents are commonly made of nitinol, the FDA and physicians are already very familiar with its properties. Nitinol stents are crimped down to be tiny enough to deliver into an artery, then, once released, they return to their original size, propping the artery open. The same property makes it possible to insert Vesteck's sutures. The extra layer of stability after the suturing procedure can potentially improve physical outcomes and psychological ones, too, Rafferty said. Without sutures, 'it's kind of like the sword of Damocles hanging over your head, because you think you got cured, but you really didn't,' he said. Progress and setbacks, as funding has become scarce Vesteck isn't available for clinical use yet, but the team has used the Suture-Tight procedure on 14 patients so far in Europe, Canada and Australia. 'Our first human patients are doing very, very well,' Rafferty said. 'The aneurysm sacs are stable or shrinking, and there's no migration, no leaks, no suture fractures.' The procedure is so simple, he said, that one of the first to use the device on a patient, a physician in Australia, successfully stitched four sutures in four minutes. For physicians with endovascular skills, it's a relatively easy procedure with little learning curve. In the US, the Vesteck team has met with the FDA six times and is ready to start the 100-patient clinical trial that would move the technology closer to being used to treat aortic aneurysm patients. Just one thing is holding them back: funding. ' Venture capital funding is way down since COVID,' Rafferty said. 'Part of that is because of the economy. For the last four years, the IPO market has been all but stagnant.' As a result, many medical device companies can't do much more than wait for money to come back into the venture capital market. 'We're kind of on hold,' Rafferty said. On the local level, several Philadelphia investors have been as enthusiastic about Vesteck as Rafferty is about Philadelphia. BioAdvance, Ben Franklin Technology Partners, Grays Ferry Capital and Robin Hood Ventures are all supporters. Still, a company like Vesteck needs big-time, global-scale funding to move forward. 'You get to a point where you need to bring in some of these larger investors,' he said, 'and that's what we're trying to do.' Beyond aortic aneurysms Despite the funding roadblocks, Rafferty is optimistic about Vesteck and its potential impact on the medical world. Physicians who have seen the technology have suggested other potential use cases, including as part of heart and vein procedures. 'A big part of our culture is keeping an open mind and understanding that different patient populations around the world have different needs, and [asking] how can we adapt this technology to suit those needs,' Rafferty said. 'That's one of the things we've learned: stay interested and stay humble.'


Technical.ly
a day ago
- Technical.ly
Pittsburgh housing authority recruits AI to help with application backlogs
Pittsburgh's housing authority will begin using artificial intelligence to help its understaffed voucher department process thousands of applications from people in need of affordable housing. On Thursday, the Housing Authority of the City of Pittsburgh (HACP) board approved payment of $160,392 to Boodskapper Inc., a private artificial intelligence company known as The company offers several services to automate housing authority work, which include reviewing and verifying certification packages from current voucher holders. The effort will begin as a one-year pilot program. Addressing concerns from the board members and a public speaker about the role the AI would play, HACP Executive Director Caster Binion stressed, 'The AI will not be in charge, not making decisions.' 'This will be used for recertifications specifically,' he added. Recertifications refer to updates affecting existing voucher holders, such as household income level and number of family members. Households with vouchers pay 30% of their income toward rent and utilities, with the balance covered by the HACP. The authority's Housing Choice Voucher Program Director Lashawna Hammond told the board the 'AI would scan recertification packets with their income and then it shows us on the back end if the packet is completed. So it's not processing, it's just doing preliminary work.' Approval of the pilot comes after Binion signaled in a meeting last year with City Council the authority would experiment with AI and other efforts to improve the efficiency of the voucher program. In 2020, PublicSource reported that the housing authority planned to 'enhance the voucher program,' but those efforts were hampered due to staffing shortages, according to the authority's leadership. Since then, steps have been taken to train new staff, according to Binion, who along with the board's former chair pledged improvements in 2022. Board member Charlise Smith worried that the program might take on human tendencies to discriminate against certain types of people. A public commenter at the board meeting echoed Smith's concerns. 'We all agree that increased efficiency is needed within the HCV Program to address administrative delays that limits the use of HCVs,' said Megan Hammond, a housing justice advocate and executive director of the Fair Housing Partnership of Greater Pittsburgh. 'AI is dependent upon the humans who create the AI. As a result, AI is susceptible to the continuation and scaling of fair housing concerns,' Hammond said, noting that the National Fair Housing Alliance created a Responsible AI Symposium that includes a framework for auditing algorithmic bias in these programs. Hammond called for 'greater transparency about the role of the proposed including checks and balances for applicants and voucher recipients to dispute inaccurate information.' She pressed for monthly public reports from the authority on the status of the Housing Choice Voucher waiting list every month along with information on where the authority allocates funds. Concerns over the use of AI in public housing has also reached the federal level. The US Department of Housing and Urban Development released guidelines for housing authorities across the country on best practices and uses of this new technology in an attempt to enforce the Fair Housing Act and prevent discrimination in housing. LaShawna Hammond maintained the program is needed to help with the backlog of recertification applications that threaten to overwhelm her staff. She noted that the system will be used to improve processing time and reduce clerical and user errors. She said the system will be able to detect missing information in the application and how that would trigger an automatic response to the client, letting them know that their application is incomplete. She said her department has 13 housing specialists, each averaging a caseload of 500. She said they hired five new housing specialists to start June 30 but it would take some time to train the new hires and bring them up to speed.


Technical.ly
3 days ago
- Technical.ly
Inside Philadelphia's startup surge: 16 ventures to watch right now
After years of developing a vibrant entrepreneurial ecosystem, Philadelphia is getting some recognition as a top startup community. A recent report from Startup Genome and the Global Entrepreneurship Network ranked Philly as the 13th best place in the world to start a company. The report called out the region's focus on life sciences, AI, big data, robotics and advanced manufacturing. Longtime ecosystem supporters like Ben Franklin Technology Partners know there's no shortage of promising new companies emerging from the Philadelphia scene, and they deserve attention for both the innovative solutions they're creating and the value they're adding to the local community. Explore the roundup below for a sampling of these notable startups, and check out the full articles to learn more about the companies and their stories. CollX CollX's app uses AI to scan, identify and price trading cards. The platform also has a marketplace, where users can buy and sell cards. CollX launched in 2021 as a tool to help trading card collectors understand the value of their cards. The platform has a visual search function that scrapes pricing data from other websites to estimate how much cards are worth. AmorSui, a sustainable personal protective equipment (PPE) company founded in Philadelphia by Beau Wangtrakuldee in 2018, was created to solve several problems with PPE, not least of which is the fact that it often doesn't fit all body types or protect from lab accidents. Finding a better lab coat — one that was designed for a smaller-framed woman rather than an average-sized man, made of material that protected the skin — turned out to be a fruitless endeavor. By 2015, when Wangtrakuldee was doing her postdoctoral fellowship at the University of Pennsylvania, she realized while taking a course on entrepreneurship that the business potential for higher quality, better-fitting lab coats was there. DrayNow Conshohocken-based DrayNow uses tech to move shipping containers on the first and last mile of their shipping journeys with a namesake app that Michael Dugas, director of business enablement for DrayNow describes as 'Uber for truck drivers.' Independent container truck drivers with their own vehicles use the DrayNow app to find jobs transporting freight. SFA Therapeutics The venture-backed SFA Therapeutics is developing multiple autoimmune disease-treating drugs, all based on a platform technology called SFA that was discovered by Mark Feitelson of Temple University, the startup's chief scientific officer. Keriton In 2016, Laura Carpenter, a lactation consultant with the Hospital at the University of Pennsylvania, set out to find a better way to manage breast milk feeding in the NICU. She wasn't a technologist herself, so she brought the challenge to Penn Engineering's PennApps hackathon, with support from the Penn Center for Innovation. The topic struck a chord with Vidur Bhatnagar, a hackathon participant who had personal experience with the NICU from the patient side. Bhatnagar would become the founder of Keriton, a NICU feeding technology app now used in dozens of hospitals across the country. Bainbridge Health The Children's Hospital of Philadelphia (CHOP) spinout Bainbridge Health has been collecting and analyzing medical data since 2016. It has a goal of streamlining the hospital data aggregation and analysis process to give clinicians the information they need to make their work both safer for the patients and more efficient, with less wasted medicine. Strados Labs Strados developed the RESP Biosensor, an FDA 510(k)-cleared wearable device that allows researchers and clinicians to remotely capture lung sounds between in-person clinical visits. The product is a wearable device that adheres to the chest. In real time, it records lung sound data and securely transfers it to a mobile app and the Strados cloud, where the sound data can be remotely identified by machine learning algorithms. The reports it generates show every cough, wheeze and crackle of the lungs, with timestamps. American Treatment Network American Treatment Network CEO Matthew Sullivan founded the Havertown, Pennsylvania-based company in 2018 to address the opioid and mental health crises by emphasizing treatment that integrates treating both addiction and mental illness by prioritizing the inpatient care that may follow an emergency room visit with accessible, ongoing outpatient care. AnaOno At the age of 27, Dana Donofree was diagnosed with breast cancer. She took her experience in fashion design and created AnaOno in 2014, a startup that makes bras designed for multiple breast cancer surgery outcomes. The name is a play on her own — it's Dana Donofree, 'DD free.' GoWell When Holly Adams worked as a benefits consultant helping businesses navigate health insurance enrollment, she knew there had to be a better way. For more than a decade, she watched as employers and employees struggled with complicated enrollment processes, long questionnaires and tech that wasn't as accessible as she knew it could be. She took what she'd learned and came up with GoWell Benefits, a platform launched in 2021 that simplifies the enrollment process for employers with an easy and accessible way to insure employees. Atalan When healthcare employees are overworked, they're likely to leave — and that can be a serious problem for the health system. Hiring is expensive. Workplaces with high turnover rates tend to have less employee satisfaction, but when employers ask their employees if they're satisfied, they don't always get straightforward answers that show what the risk of burnout really is. To address these issues, startup founders Tiffany Chan and Sisi Hu, an engineer and a postdoc labor economist who met doing climate change work at Harvard School of Engineering and Applied Sciences, cofounded Atalan, a mission-oriented company with a platform that uses machine learning to help healthcare systems identify workplace risk factors that drive healthcare professionals to leave, in 2022. Yellowdig Yellowdig, a community-focused learning platform, was founded in 2015 by Shaunak Roy. At the time, highly collaborative experiential learning was an impactful trend in education — one that took a hit when the pandemic moved students out of classrooms and into virtual meetings. That shift was an opportunity for Yellowdig. Yellowdig uses technology to foster a more experiential learning environment with engagement and collaboration that enhances what students learn in the classroom. Lithero In life sciences, everything takes longer. Nyron Burke, cofounder and CEO of the Philadelphia-based AI for life sciences company Lithero, learned that through years of working as a consultant with pharmaceutical companies that were always looking for ways to speed up the process of creating marketing materials. What may seem relatively simple, like a pharmaceutical pamphlet for a doctor's office, can take months to finalize due to compliance issues. The final draft, with its medical language and side effects disclosures, has to be just right, requiring multiple reviews by medical lawyers before it goes to print. Burke founded Lithero in 2015, years before AI became a common part of everyday life. He knew that machine learning could make the process considerably faster by screening for compliance issues before a medical lawyer reviews it, cutting down on the number of reviews — and, crucially, time. Tolerance Bio Tolerance Bio focuses on preserving the body's immune system by restoring the function of an organ called the thymus. The organ, long believed to be as useful in adults as the appendix (that is, not at all), may actually be the key to slower aging and prolonged life spans. Now, Tolerance Bio is moving toward the first trials of its proprietary stem cell therapy, focusing first on children born without a thymus. Audigent Audigent's framework for advertisers and publishers allows customers to target their key demographics, as all adtech tools do. The difference with Audigent, now headquartered in NYC, is that it prioritizes the privacy of its potential customers by never using cookies (those small files that websites use to track users' online behavior). Instead, it uses data from partners, like music streamers, media companies and sports sites. Lula Commerce Lula Commerce provides a platform for small retailers to offer online shopping and delivery to their customers using popular apps like DoorDash, UberEats and GrubHub, making it easy for their customers to do business with them online. With Lula, stores that may not have the resources to hire their own team of developers can have a site that integrates multiple ecommerce channels, direct customer service, inventory and returns. In the four years since its founding, the company has rapidly expanded to serve thousands of locations across 44 states.